Effectiveness of humanized anti-interleukin-6 receptor monoclonal antibody (MRA) in secondary osteoporosis complicated with rheumatoid arthritis

被引：0
|
作者：
Saito, K
Okada, Y
Nakatsuka, K
Yoshizaki, K
Kishimoto, T
Nishimoto, N
Tanaka, Y
机构：
[1] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka 807, Japan
[2] Osaka Univ, Suita, Osaka 565, Japan
来源：
BONE | 2003年 / 32卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S77 / S77
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of repetitive treatment with humanized anti-interleukin-6 receptor antibody (MRA) in rheumatoid arthritis (RA).
    Nishimoto, N
    Maeda, K
    Kuritani, T
    Deguchi, H
    Sato, B
    Imai, N
    Kakehi, T
    Suemura, M
    Kishimoto, T
    Yoshizaki, K
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S84 - S84
  • [2] Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis
    Mihara, Masahiko
    Ohsugi, Yoshiyuki
    Kishimoto, Tadamitsu
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2011, 3 : 19 - 29
  • [3] Imaging of lesions in a murine rheumatoid arthritis model with a humanized anti-interleukin-6 receptor antibody
    Sugimoto, K
    Nishimoto, N
    Kishimoto, T
    Yoshizaki, K
    Nishimura, T
    ANNALS OF NUCLEAR MEDICINE, 2005, 19 (04) : 261 - 266
  • [4] Imaging of lesions in a murine rheumatoid arthritis model with a humanized anti-interleukin-6 receptor antibody
    Kanji Sugimoto
    Norihiro Nishimoto
    Tadamitsu Kishimoto
    Kazuyuki Yoshizaki
    Tsunehiko Nishimura
    Annals of Nuclear Medicine, 2005, 19 : 261 - 266
  • [5] Humanized anti-interleukin-6 receptor antibody
    Larry Moreland
    Current Rheumatology Reports, 2005, 7 (5) : 381 - 381
  • [6] Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis
    Koike, Ryuji
    Harigai, Masayoshi
    Atsumi, Tatsuya
    Amano, Koichi
    Kawai, Shinichi
    Saito, Kazuyoshi
    Saito, Tomoyuki
    Yamamura, Masahiro
    Matsubara, Tsukasa
    Miyasaka, Nobuyuki
    MODERN RHEUMATOLOGY, 2009, 19 (04) : 351 - 357
  • [7] Pharmacotherapy Options in Rheumatoid Arthritis: Focus on Tocilizumab, a Recombinant Humanized Anti-Interleukin-6 Receptor Antibody
    Ohsugi, Yoshiyuki
    Kishimoto, Tadamitsu
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1677 - 1691
  • [8] Intracellular Dynamics and Fate of a Humanized Anti-Interleukin-6 Receptor Monoclonal Antibody, Tocilizumab
    Fujimoto, Keiko
    Ida, Hiroaki
    Hirota, Yuko
    Ishigai, Masaki
    Amano, Jun
    Tanaka, Yoshitaka
    MOLECULAR PHARMACOLOGY, 2015, 88 (04) : 660 - 675
  • [9] Successful Treatment of Reactive Arthritis With a Humanized Anti-Interleukin-6 Receptor Antibody, Tocilizumab
    Tanaka, Toshio
    Kuwahara, Yusuke
    Shima, Yoshihito
    Hirano, Toru
    Kawai, Mari
    Ogawa, Masako
    Arimitsu, Junsuke
    Hagihara, Keisuke
    Narazaki, Masashi
    Ogata, Atsushi
    Kawase, Ichiro
    Kishimoto, Tadamitsu
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (12): : 1762 - 1764
  • [10] TREATMENT OF SEVERE RHEUMATOID-ARTHRITIS BY ANTI-INTERLEUKIN-6 MONOCLONAL-ANTIBODY
    WENDLING, D
    RACADOT, E
    WIJDENES, J
    JOURNAL OF RHEUMATOLOGY, 1993, 20 (02) : 259 - 262
12345